CVR number 40728929
Industry 86.9090 Other human health activities

CFA Viborg ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.8% 0.8% 0.8% 0.8% 0.8%  
Bankruptcy risk  0.0% 10.7% 9.1% 12.0% 15.0%  
Credit score (0-100)  0 23 26 19 13  
Credit rating  N/A BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  0.0 448 442 522 562  
EBITDA  0.0 -8.0 -5.4 -15.1 64.0  
EBIT  0.0 -12.5 -9.9 -19.6 64.0  
Pre-tax profit (PTP)  0.0 -13.8 -14.3 -30.0 57.5  
Net earnings  0.0 -11.2 -12.1 -24.7 42.6  
Pre-tax profit without non-rec. items  0.0 -13.8 -14.3 -30.0 57.5  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 9.0 4.5 0.0 0.0  
Shareholders equity total  0.0 32.9 20.8 -3.9 38.7  
Interest-bearing liabilities  0.0 0.9 0.1 11.8 0.4  
Balance sheet total (assets)  0.0 183 104 88.7 138  
Net Debt  0.0 -157 -77.7 -27.7 -120  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 448 442 522 562  
Gross profit growth  0.0% 0.0% -1.2% 18.1% 7.6%  
Employees  0 1 1 2 2  
Employee growth %  0.0% 0.0% 0.0% 100.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 183 104 89 138  
Balance sheet change%  0.0% 0.0% -43.2% -14.8% 55.5%  
Added value  0.0 -8.0 -5.4 -15.1 64.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 5 -9 -9 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 -3.0 1.0  

Profitability 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% -2.8% -2.2% -3.8% 11.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% -6.8% -6.9% -19.9% 55.5%  
ROI %  0.0% -37.1% -36.1% -119.9% 251.6%  
ROE %  0.0% -34.1% -45.0% -45.1% 66.9%  

Solidity 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  0.0% 17.9% 20.0% -4.2% 28.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 1,951.6% 1,444.8% 183.7% -186.9%  
Gearing %  0.0% 2.9% 0.4% -301.8% 0.9%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 264.0% 857.0% 176.2% 105.7%  

Liquidity 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.0 1.3 1.2 0.9 1.3  
Current Ratio  0.0 1.3 1.2 0.9 1.3  
Cash and cash equivalent  0.0 157.6 77.8 39.5 119.9  

Capital use efficiency 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 39.5 16.3 -12.9 29.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 -8 -5 -8 32  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 -8 -5 -8 32  
EBIT / employee  0 -13 -10 -10 32  
Net earnings / employee  0 -11 -12 -12 21